Edition:
United States

Amarin Corporation PLC (AMRN.OQ)

AMRN.OQ on NASDAQ Stock Exchange Global Market

3.45USD
4:00pm EDT
Change (% chg)

$0.09 (+2.68%)
Prev Close
$3.36
Open
$3.39
Day's High
$3.49
Day's Low
$3.36
Volume
448,362
Avg. Vol
288,550
52-wk High
$3.65
52-wk Low
$1.90

AMRN.OQ

Chart for AMRN.OQ

About

Amarin Corporation plc is a biopharmaceutical company with operations in lipid science focused on the commercialization and development of therapeutics for cardiovascular health. The Company operates through the development and commercialization of Vascepa segment. The Company's lead product, Vascepa (icosapent ethyl) capsule,... (more)

Overall

Beta: 0.73
Market Cap(Mil.): $914.90
Shares Outstanding(Mil.): 272.29
Dividend: --
Yield (%): --

Financials

  AMRN.OQ Industry Sector
P/E (TTM): -- 239.63 19.01
EPS (TTM): -0.33 -- --
ROI: -78.95 -8.17 -5.03
ROE: -- -11.48 -4.28

BRIEF-Amarin says vascepa showed reductions in potentially atherogenic lipid parameters

* Amarin says vascepa showed reductions in potentially atherogenic lipid parameters in statin-treated women with type 2 diabetes and persistent high triglycerides

Jun 12 2017

BRIEF-Amarin Q1 loss per share $0.08

* Amarin reports first quarter 2017 financial results and provides update on operations

May 03 2017

BRIEF-Amarin reaches the onset of about 80 pct of the target aggregate number within the reduce-it study

* Amarin reaches the onset of approximately 80% of the target aggregate number of primary major adverse cardiovascular events within the reduce-it study

Mar 16 2017

BRIEF-Amarin files for resale by the selling shareholders' of up to 10.4 mln shares- SEC filing

* Amarin Corp Plc files for resale by the selling shareholders of up to 10.4 million American Depositary Shares - SEC filing Source text for Eikon: Further company coverage:

Mar 01 2017

BRIEF-Amarin Corp files for potential mixed shelf - SEC filing

* Amarin Corporation Plc files for potential mixed shelf; size not disclosed - sec filing Source text for Eikon: Further company coverage:

Mar 01 2017

BRIEF-Amarin reports posts Q4 loss per share $0.10

* Amarin reports record fourth quarter and full year 2016 financial results and provides update on operations

Feb 28 2017

BRIEF-Amarin says debt restructuring and related private placement of exchangeable senior notes

* Amarin announces debt restructuring and related private placement of exchangeable senior notes

Jan 20 2017

More From Around the Web

Competitors

Earnings vs. Estimates